Hologic Q3 FY2025 revenue $1.024B beats guidance; non-GAAP EPS $1.08 exceeds high-end

HOLOGIC INC

2025-Q3 EPS reported $1.66 revenue$3,050,900,000

Revenue $1,023.8M, +1.2% YoY, above guidance of $1,000-$1,010M.
GAAP diluted EPS $0.86 (+4.9%); non-GAAP diluted EPS $1.08 (+1.9%), above guidance $1.04-$1.07.
Diagnostics revenue $448.9M (+1.8%); organic diagnostics ex-COVID grew 3.9%.
Breast Health revenue $365.2M (-5.1%); organic breast health declined 10.1% ex-divestiture and acquisition.
Surgical revenue $178.4M (+7.1%); organic surgical up 2.0% ex-Gynesonics.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.